A case of unresectable combined hepatocellular and cholangiocarcinoma treated with atezolizumab plus bevacizumab

An 81‐year‐old man initially underwent right hepatic lobectomy for liver cancer and was pathologically diagnosed with combined hepatocellular and cholangiocarcinoma (CHC). At 13 months after resection, multiple lymph node metastases were observed. We started atezolizumab plus bevacizumab (Atez/Bev),...

Descripción completa

Detalles Bibliográficos
Autores principales: Saito, Naoto, Hatanaka, Takeshi, Nakano, Sachi, Hazama, Yoichi, Yoshida, Sachiko, Hachisu, Yoko, Tanaka, Yoshiki, Yoshinaga, Teruo, Kashiwabara, Kenji, Kubo, Norio, Hosouchi, Yasuo, Tojima, Hiroki, Kakizaki, Satoru, Uraoka, Toshio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309740/
https://www.ncbi.nlm.nih.gov/pubmed/35898742
http://dx.doi.org/10.1002/ccr3.6129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9309740/
https://www.ncbi.nlm.nih.gov/pubmed/35898742
http://dx.doi.org/10.1002/ccr3.6129

Ejemplares similares